Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 26, 2021
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational studyGiorgia Mangili, Giorgio Giorda, Gabriella Ferrandina, et al.
Breast Cancer Research and Treatment|May 4, 2006
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patientsMarco Tampellini, Alfredo Berruti, Raffaella Bitossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial designAlfredo Berruti, Raffaella Bitossi, Gabriella Gorzegno, et al.
Clinical Breast Cancer|October 28, 2008
Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib eraFilippo Montemurro, Stefania Redana, Giuseppe Viale, et al.
BMC Cancer|January 10, 2006
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective studySandro Pignata, Sabino De Placido, Rosalbino Biamonte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized studySabino De Placido, Giovanni Scambia, Giovanni Di Vagno, et al.
Tumori|December 14, 2011
Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network StudyLuca Fuso, Andrea Evangelista, Eva Pagano, et al.
BMC Medicine|November 22, 2019
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trialMaria Vittoria Dieci, Giancarlo Bisagni, Alba A Brandes, et al.
Pageof 3